Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18/F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET) IMAGING IN THE MANAGEMENT OF PATIENTS WITH SOLITARY PULMONARY NODULES

NCT00032331 is registered in ClinicalTrials.gov with US Department of Veterans Affairs as lead sponsor.

NCT NCT00032331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00032331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18/F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET) IMAGING IN THE MANAGEMENT OF PATIENTS WITH SOLITARY PULMONARY NODULES
Lead sponsor
US Department of Veterans Affairs
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1999
Completion date
June 30, 2003
Enrollment
500
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign and malignant solitary pulmonary nodules